Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue April 2015
 •  Balmex Sold To Moberg Pharma  •  Bye, Bye P&G...  •  Tide and Gain Roll Out 'Up, Up and Away'  •  Carma Labs Names New VP of R&D  •  Tide Professional Coldwater System Honored
Print

Del Laboratories: William McMenemy



Published November 22, 2005
Related Searches: president sales ink financial
Post a comment
Del Laboratories: Following the acquisition of Del by DLI Holding Corp. later this year, Dan K. Wassong will retire. William McMenemy, currently executive vice president of marketing at Del will become president and chief executive officer. Charles J. Hinkaty, vice president of Del and president of Del Pharmaceuticals, will become chief operating officer. Harvey Alstodt, currently executive vice president of sales, will become president of global business. Enzo J. Vialardi will remain executive vice president and chief financial officer of Del.


blog comments powered by Disqus